EPISODE · Jun 10, 2026 · 5 MIN
First JCA Report and Oral Semaglutide Approval
Episode 27 — 10 June 2026 The EU published its first Joint Clinical Assessment report for tovorafenib while EMA approved oral semaglutide for weight management. JCA capacity constraints emerge as demand for scientific advice exceeds available slots. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Embed this episode
Ready to play
First JCA Report and Oral Semaglutide Approval
0:00
5:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Carl Haakon's Podcast?
This episode is 5 minutes long.
When was this Carl Haakon's Podcast episode published?
This episode was published on June 10, 2026.
Can I download this Carl Haakon's Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!